Immunic Inc (IMUX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

AM KLOPFERSPITZ 19 MARTINSRIED, GERMANY 82152

Vital Therapies, Inc. develops and discovers cell based therapies. The Company designs and produces medical cartridges to stabilize liver function in patients. Vital Therapies serves customers worldwide.

Data as of 2021-07-19 09:18:25 -0400
Market Cap208.36 Million Shares Outstanding21.749 Million Avg 30-day Volume359.17 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.12 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.9479 52-week High/Low28.21 / 9.06 Next Earnings Date2021-08-06 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from IMUX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 66 74 -10.81% 19 (1.12%) 22 (1.28%) -13.64%
13F shares: 9.301 Million 9.728 Million -4.39% 4.754 Million 4.839 Million -1.77%
% Ownership 43.9393 46.9547 -6.42% 22.4569 23.3583 -3.86%
New Positions: 6 14 -57.14% 2 3 -33.33%
Increased Positions 18 28 -35.71% 4 9 -55.56%
Closed Positions 13 7 85.71% 5 2 150.0%
Reduced Positions 23 15 53.33% 8 7 14.29%
Total Calls 90.051 Thousand 148.906 Thousand -39.52% 43.1 Thousand 33.204 Thousand 29.8%
Total Puts 52.755 Thousand 19.418 Thousand 171.68%
PUT/CALL Ratio 0.59 0.13 353.85% 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IMUX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IMUX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NASH DUANE EXECUTIVE CHAIRMAN

  • Officer
  • Director
10,000 2021-06-10 4

VAN DEN BOSSCHE JAN

  • Director
10,000 2021-06-10 1

NEERMANN JOERG

  • Director
10,000 2021-06-10 1

OSSIPOW VINCENT

  • Director
25,000 2021-06-10 1

HOWSON TAMAR D

  • Director
10,000 2021-06-10 1

PHILLIPS BARCLAY A

  • Director
10,000 2021-06-10 1

MUEHLER ANDREAS CHIEF MEDICAL OFFICER

  • Officer
294,486 2021-03-10 2

WHALEY GLENN PFO AND PAO

  • Officer
2,000 2021-03-02 3

GROEPPEL MANFRED CHIEF OPERATING OFFICER

  • Officer
45,000 2021-03-01 1

VITT DANIEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
115,000 2021-03-01 1

PATEL SANJAY S CHIEF FINANCIAL OFFICER

  • Officer
0 2019-07-22 0

GLOBAL LIFE BIOVENTURE V SARL

OMEGA FUND V, L.P.

OMEGA FUND V GP, L.P.

OMEGA FUND V GP MANAGER, LTD.

LIM RICHARD J.

STAMPACCHIA OTELLO

NESSI CLAUDIO

PASTER ANNE-MARI

  • 10% Owner
1,371,494 2019-04-12 0

LSP V COOPERATIEVE U.A.

LSP V MANAGEMENT B.V.

  • 10% Owner
2,162,782 2019-04-12 0

FUND N.V.

  • 10% Owner
1,371,494 2019-04-12 0

DUNN JOHN MICHAEL GENERAL COUNSEL AND SECRETARY

  • Officer
0 2019-01-11 0

SWANSON MICHAEL V. CHIEF FINANCIAL OFFICER, EVP

  • Officer
0 2019-01-11 0

ASHLEY ROBERT A. CHIEF SCIENTIFIC OFFICER, EVP

  • Officer
0 2019-01-11 0

COX RUSSELL J. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-01-11 0

HALPERIN ERROL R.

  • Director
0 2018-09-25 0

BIENAIME JEAN JACQUES

  • Director
18,500 2018-09-24 0

GODSHALL DOUGLAS EVAN

  • Director
0 2018-09-19 0

SATTER MUNEER A

  • Director
  • 10% Owner
0 2018-09-13 0

HASNAIN FAHEEM

  • Director
8,000 2018-09-13 0

COHEN CHERYL

  • Director
0 2018-09-12 0

STERN ARON CHIEF ADMINISTRATIVE OFFICER

  • Officer
0 2018-07-01 0

HENRY ANDREW VP, CLINICAL OPERATIONS

  • Officer
0 2018-06-09 0

MURAWSKI RICHARD M VICE PRESIDENT, MANUFACTURING

  • Officer
0 2018-06-09 0

SEARS LOWELL

  • Director
0 2018-05-23 0

MILLIS J. MICHAEL

  • Director
0 2018-05-23 0

WINTERS TERENCE E. CO-CHAIRMAN AND CEO

  • Officer
  • Director
314,930 2017-06-14 0

CROXFORD PHILIP M

  • Director
0 2017-05-23 0

STEER RANDOLPH C

  • Director
0 2017-05-23 0

LOEWEN ANDREA SEE REMARKS

  • Officer
0 2016-05-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HOWSON TAMAR D - Director

2021-06-14 17:02:11 -0400 2021-06-10 A 10,000 a 10,000 direct

NASH DUANE - Director - Officer EXECUTIVE CHAIRMAN

2021-06-14 19:13:02 -0400 2021-06-10 A 10,000 a 10,000 direct

NEERMANN JOERG - Director

2021-06-14 17:01:29 -0400 2021-06-10 A 10,000 a 10,000 direct

OSSIPOW VINCENT - Director

2021-06-14 17:02:39 -0400 2021-06-10 A 25,000 a 25,000 direct

PHILLIPS BARCLAY A - Director

2021-06-14 17:01:55 -0400 2021-06-10 A 10,000 a 10,000 direct

VAN DEN BOSSCHE JAN - Director

2021-06-14 17:01:02 -0400 2021-06-10 A 10,000 a 10,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
IMMUNIC INC IMUX 2021-07-23 22:15:03 UTC -0.6793 0.7593 400000
IMMUNIC INC IMUX 2021-07-23 21:45:03 UTC -0.6793 0.7593 400000
IMMUNIC INC IMUX 2021-07-23 21:15:03 UTC -0.6793 0.7593 400000
IMMUNIC INC IMUX 2021-07-23 20:45:03 UTC -0.6793 0.7593 400000
IMMUNIC INC IMUX 2021-07-23 20:15:05 UTC -0.6793 0.7593 400000
IMMUNIC INC IMUX 2021-07-23 19:45:03 UTC -0.543 0.623 400000
IMMUNIC INC IMUX 2021-07-23 19:15:03 UTC -0.543 0.623 400000
IMMUNIC INC IMUX 2021-07-23 18:45:03 UTC -0.556 0.636 400000
IMMUNIC INC IMUX 2021-07-23 18:15:03 UTC -0.556 0.636 400000
IMMUNIC INC IMUX 2021-07-23 17:45:03 UTC -0.556 0.636 400000
IMMUNIC INC IMUX 2021-07-23 17:15:02 UTC -0.556 0.636 400000
IMMUNIC INC IMUX 2021-07-23 16:45:02 UTC -0.5416 0.6216 400000
IMMUNIC INC IMUX 2021-07-23 16:15:03 UTC -0.5416 0.6216 400000
IMMUNIC INC IMUX 2021-07-23 15:45:02 UTC -0.5416 0.6216 400000
IMMUNIC INC IMUX 2021-07-23 15:15:03 UTC -0.5416 0.6216 400000
IMMUNIC INC IMUX 2021-07-23 14:45:03 UTC -0.643 0.723 400000
IMMUNIC INC IMUX 2021-07-23 14:15:03 UTC -0.643 0.723 400000
IMMUNIC INC IMUX 2021-07-23 13:45:03 UTC -0.643 0.723 400000
IMMUNIC INC IMUX 2021-07-23 13:15:03 UTC -0.643 0.723 400000
IMMUNIC INC IMUX 2021-07-23 12:45:03 UTC -0.643 0.723 400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
INVESTMENT MANAGERS SERIES TRUST- 361 Domestic Long/Short Equity Fund IMUX -4098.0 shares, $-62945.28 2021-04-30 N-PORT

Elevate your investments